Efficacy of liraglutide QD vs. sitagliptin QD vs. insulin glargine on liver fat when combined with metformin in T2DM subjects with NAFLD

Trial Profile

Efficacy of liraglutide QD vs. sitagliptin QD vs. insulin glargine on liver fat when combined with metformin in T2DM subjects with NAFLD

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Sep 2016

At a glance

  • Drugs Liraglutide (Primary) ; Insulin glargine; Metformin; Sitagliptin
  • Indications Non-alcoholic fatty liver disease; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Aug 2016 Status changed from not yet recruiting to completed.
    • 02 Jul 2014 New trial record
    • 21 May 2014 Planned End Date changed from 1 Apr 2016 to 1 Mar 2016 as reported by Chinese Clinical Trial Register.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top